SLC2A1 and esophageal squamous cell carcinoma: The fluorescent glucose analog 2-DG 800CW exploits the high expression of the glucose transporter GLUT1 on tumor cells to detect high-grade dysplasia (HGD) and early esophageal squamous cell carcinoma (ESCC).